The myth about reputation in an M&A deal: either it doesn't matter, or it wrecks everything

Among business owners preparing for a sale, a mistaken split is common: either the digital footprint doesn't matter — "the buyer cares about the numbers, not search results" — or, conversely, one bad finding can sink the whole deal. Neither describes what actually happens in buy-side due diligence. The overwhelming majority of reputational findings don't go unnoticed, and they don't kill the deal — they change its terms: price, payment structure, the scope of warranties.

The example below is a composite, built from patterns typical of several middle-market deals; it does not describe a real company, deal, or buyer.

A co-owner of a regional distribution company with roughly $45 million in revenue had agreed to sell a controlling stake to an industry consolidator — a strategic buyer that already owned several similar assets. The financial and corporate portions of due diligence went smoothly. But the buyer's team, in addition to lawyers and auditors, brought in a compliance and reputational-screening contractor — and during the exclusivity period, it surfaced three findings: an old note about a five-year-old customs dispute, formally closed by a settlement but with not a single public line about the resolution; a mention of one of the seller's previously liquidated affiliated entities in an offshore-data leak — with no criminal context, but no explanation either; and a scattered digital profile for the seller himself, in which three language versions of his name spelling diverged enough that the buyer's team spent nearly two weeks just figuring out which of the mentions found even related to the seller.

No single finding was fatal on its own, and the buyer wasn't considering walking away from the deal. But taken together, it used them as grounds for three decisions at once: it requested a price reduction (a price chip) of a few percentage points off the deal value, insisted on an increased holdback — a portion of payment held in a separate account for 18 months — and, since the deal was structured with representations & warranties insurance (W&I insurance), the policy's underwriter included a specific exclusion covering all three findings: if a claim tied to any of them arises in the future, the policy won't cover it, and liability stays with the seller directly. The deal closed — but on terms noticeably worse than those discussed before confirmatory due diligence began.

Who's on the other side of the table in an M&A deal

Screening a seller's and their company's reputation ahead of a deal isn't a single review — it's several parallel processes with different objectives, and the cast of participants depends on the type of buyer.

The corp-dev and legal team of a strategic buyer. If the buyer is an industry consolidator, it cares not about abstract image but about reputational integration: will the acquired asset create a brand risk for the group after closing, are there hidden conflicts with the buyer's current partners or clients.

The investment committee and operating partners of a private equity fund. If the buyer is a fund, it assesses how manageable the risk is over the entire holding horizon (typically 3-7 years) and, importantly, with an eye to its own future exit: the fund remembers that it will itself become a seller facing the next buyer one day, and doesn't want to inherit a finding it will have to explain on its own side of a future deal.

The buy-side compliance and reputational contractor. A specialized screening firm hired by the buyer specifically for this deal prepares a red-flag report for the lawyers running the SPA — it doesn't participate directly in the deal decision, but it forms the core body of facts the subsequent negotiations are built on.

The W&I policy underwriter — if the deal is structured with representations & warranties insurance. It doesn't take part in the deal decision itself, but decides what falls under insurance coverage and what remains an exclusion: known issues, already known at the time of underwriting, are almost guaranteed to be excluded from coverage — logic that's close to how a D&O insurer works in pre-IPO deals, but with its own timeline and its own set of questions.

Unlike a pre-IPO round, where the decision rests with a syndicate of institutional investors and the public-offering's underwriting bank, in an M&A deal the circle of participants is narrower, and the tools that convert a finding into terms are more technical, written directly into the SPA text rather than shaped by broad market perception at a roadshow. A detailed breakdown of how a similar review works before an IPO, and how it systematically differs, is covered in "Digital Footprint Before an IPO: What Investors and Underwriters Check."

See also · ArticleDigital Footprint Before an IPO: What Investors and Underwriters CheckA related but different deal scenario: how an investment committee and an underwriting syndicate assess a founder's digital footprint ahead of a public offering.Read the article →

A technical screening error also frequently surfaces at this stage — a beneficiary's name coinciding with someone else's entry on a sanctions list, which calls for a procedural response rather than a negotiated one. The logic for resolving it differs from the logic behind a price chip or holdback: a similar case is covered in "A False Match on a Sanctions List: Unblocking an Account in 7 Weeks." We covered status in open sanctions and PEP databases, and the mechanics of correcting an inaccurate entry through the database operator, separately in "World-Check and PEP Status."

"In an M&A deal, a reputational finding is almost never a choice between 'deal' and 'no deal' — the buyer simply shifts the risk into the price, into a holdback, or into a W&I policy exclusion. What costs the seller the most isn't the finding itself, but its uncertainty: if the buyer doesn't have clear, documented context, they price the risk at its maximum, not at the problem's actual scale."

The Aegis Reputation Lab team

AEGIS position

Three channels through which a finding gets built into the SPA

When a buy-side review turns up a reputational or compliance risk, the buyer has a practical choice — not walking away from the deal, but one of the tools that go straight into the text of the share purchase agreement (SPA) or its schedules.

01

Price chip

A direct price adjustment in negotiations after confirmatory due diligence — the buyer justifies a discount with a specific finding and folds it into the final deal amount, or shifts part of the price into an earn-out, making it conditional.

02

Holdback / escrow

A portion of the deal value — typically from a few percentage points up to 10-20% of the price — is held in a separate account for 12-24 months and released only if no claim tied to the identified risk arrives within that period.

03

W&I policy exclusion

If the deal is insured under representations & warranties, the underwriter won't cover risks already known at the time the policy is signed. A finding uncovered during due diligence almost automatically becomes a specific exclusion — liability for it stays with the seller directly.

If a finding is serious enough — calling asset ownership into question, uncovering undisclosed liabilities, or an actual (not mistaken) match with a sanctions list — the buyer is entitled to walk away from the deal as early as confirmatory due diligence, before the SPA is signed. A deal collapse at this stage happens less often than the three tools above, which is exactly why findings of this magnitude are better resolved in advance rather than explained in the middle of a review.

Deal timeline: what gets checked at each stage, and when there's still time to fix things

Reputational due diligence in M&A isn't a one-time event — it intensifies as the deal moves from term sheet to closing, and the window for fixing a finding narrows at every subsequent stage.

Deal stage What the buyer assesses at this stage How much room is left to fix a finding
LOI / term sheet Preliminary screening by the internal corp-dev team or the fund partner: a quick check of public sources, court databases, and open sanctions lists for the seller and key beneficiaries Full window: root causes can be addressed, documented context can be prepared, and procedures requiring months can be initiated if needed
Exclusivity period A full buy-side DD team is assembled: lawyers, a compliance contractor, and — if W&I insurance is involved — the policy broker prepares the underwriting submission The window narrows: work with primary sources is still possible, but there's no time left for measures that take months — systematic publication work, for instance
Confirmatory due diligence Deep review: the compliance contractor's red-flag report, archived versions of publications, data leaks and offshore registries, beneficiaries' social media, a re-check of the ownership structure Narrow window: mostly limited to contextualizing and documenting already-known facts — emergency edits at this point read as an additional red flag themselves
SPA negotiation Findings get converted into specific terms: price chip, holdback/escrow, indemnity, specific representations and warranties, W&I policy exclusions The work shifts to the lawyers: representation and warranty wording gets negotiated, but the fact itself has already been assessed and built into the deal structure
Closing and the escrow holding period Representations and warranties become a post-closing risk; releasing the holdback depends on no claims arising within the agreed period The goal shifts from "fix it" to "prevent a claim" during the holding period — steady monitoring matters more than any after-the-fact intervention

What to do 12-18 months before starting a sale

The preparation horizon for selling a business is usually longer than for a pre-IPO roadshow: owners rarely reach an LOI out of nowhere, and most have 12-18 months to run their own review before the buyer does. This isn't a technical formality — it's a way of controlling the form in which a finding, if there is one, lands on the buyer's desk: as a fact explained and documented in advance, or as a surprise in the middle of confirmatory due diligence.

  1. Run your own digital-footprint audit of the company, key beneficiaries, and current management — using the same methods the buyer's buy-side contractor will use.
  2. Check for mentions of affiliated and previously liquidated entities in offshore registries and known data leaks, even if the entities themselves have long been inactive.
  3. Document settled court and customs disputes from past years together with the company's lawyers — before they have to be reconstructed under the pressure of a confirmatory DD deadline.
  4. Set up mention monitoring for the company and its beneficiaries throughout the sale preparation period and the exclusivity period with the buyer.
  5. Discuss with M&A lawyers, and, if the deal involves W&I insurance, with the policy broker, which findings could realistically end up as exclusions, and address the manageable part of the risk in advance.
  6. Put the company's and its founder's digital profile in order across open sources, including consistent name-spelling versions across languages — this reduces the number of clarifying questions during confirmatory DD and speeds up the process.
ServiceCompliance Risk Assessment Before DealsDiscuss →

What to do next

A digital footprint isn't checked just once during a business sale — it's re-examined at every subsequent stage: lightly at the LOI, more deeply during exclusivity, at maximum depth during confirmatory due diligence. Work started 12-18 months before the sale process begins solves two problems at once: it lowers the odds that a finding ever becomes a negotiating point, and, if a finding does exist, it provides ready, documented context that reduces its effect on the price chip, holdback, and W&I policy terms. Aegis Reputation Lab doesn't replace M&A lawyers or W&I insurance brokers — the work runs in sync with them: the seller's and company's digital profile, a compliance file on disputed findings, and monitoring for the full duration of the deal, while legal and insurance decisions stay with the client's own specialist advisers.

Frequently asked questions